Market Updates

The Pharmaceutical Benefit Advisory Committee (PBAC) met in March 2025 and reviewed 47 applications. 32 of these applications where Recommended, 10 Not Recommended and 5 where wither deferred or not applicable.The accompanying graphs show the breakdown by category of each application success.